Related references
Note: Only part of the references are listed.Clinical Significance of Circulating Tumor Cells, Including Cancer Stem-Like Cells, in Peripheral Blood for Recurrence and Prognosis in Patients With Dukes' Stage B and C Colorectal Cancer
Hisae Iinuma et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer
Ramon Salazar et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction
Bernhard Mlecnik et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up
R. Labianca et al.
ANNALS OF ONCOLOGY (2010)
Experimentally Derived Metastasis Gene Expression Profile Predicts Recurrence and Death in Patients With Colon Cancer
J. Joshua Smith et al.
GASTROENTEROLOGY (2010)
Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin
Michael J. O'Connell et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
Daniel J. Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
Arnaud D. Roth et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic and Predictive Biomarkers in Resected Colon Cancer: Current Status and Future Perspectives for Integrating Genomics into Biomarker Discovery
Sabine Tejpar et al.
ONCOLOGIST (2010)
CpG-island methylation of the ER promoter in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients
J. Harder et al.
BRITISH JOURNAL OF CANCER (2009)
KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803
Shuji Ogino et al.
CLINICAL CANCER RESEARCH (2009)
Association of Inflammation-Related and microRNA Gene Expression with Cancer-Specific Mortality of Colon Adenocarcinoma
Aaron J. Schetter et al.
CLINICAL CANCER RESEARCH (2009)
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
Shuji Ogino et al.
GUT (2009)
Association of GUCY2C Expression in Lymph Nodes With Time to Recurrence and Disease-Free Survival in pN0 Colorectal Cancer
Scott A. Waldman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
Franck Pages et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Colon Cancer
Paul F. Engstrom et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2009)
CD3+cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study
Luigi Laghi et al.
LANCET ONCOLOGY (2009)
BRAF Mutation in Metastatic Colorectal Cancer.
Jolien Tol et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer
Amy J. French et al.
CLINICAL CANCER RESEARCH (2008)
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma
Aaron J. Schetter et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Federica Di Nicolantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
Rafael G. Amado et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer
Yuqiu Jiang et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
K-ras mutations and benefit from cetuximab in advanced colorectal cancer
Christos S. Karapetis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer
Georg Lurje et al.
PHARMACOGENETICS AND GENOMICS (2008)
被撤回的出版物: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunities (Retracted Article. See vol 106, pg 6878, 2009)
Katherine S. Garman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study
Richard Gray et al.
LANCET (2007)
Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection
Yih-Huei Uen et al.
ANNALS OF SURGERY (2007)
Molecular prognostic markers in locally advanced colon cancer
Georg Lurje et al.
CLINICAL COLORECTAL CANCER (2007)
Who to treat with adjuvant therapy in Dukes B/stage II colorectal cancer? The need for high quality pathology
Eva J. A. Morris et al.
GUT (2007)
A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer
Chew Yee Ngan et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer
Yu-Hsin Lin et al.
CLINICAL CANCER RESEARCH (2007)
Stage II colon cancer prognosis prediction by tumor gene expression profiling
Alain Barrier et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancer
Moritz Koch et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Immunohistochemical test for MLH1 and MSH2 expression predicts clinical outcome in stage II and III colorectal cancer patients
Giovanni Lanza et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Functional categories of TP53 mutation in colorectal cancer:: results of an International Collaborative Study
B Iacopetta et al.
ANNALS OF ONCOLOGY (2006)
Current issues in adjuvant treatment of stage II colon cancer
Thierry Andre et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Effector memory T cells, early metastasis, and survival in colorectal cancer
F Pagès et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Molecular staging for survival prediction of colorectal cancer patients
S Eschrich et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival
J Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Loss of heterozygosity: An independent prognostic factor of colorectal cancer
Shih-Ching Chang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Systematic review of microsatellite instability and colorectal cancer prognosis
S Popat et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis
S Popat et al.
EUROPEAN JOURNAL OF CANCER (2005)
Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas
K Fransén et al.
CARCINOGENESIS (2004)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
Thymidylate synthase expression and prognosis in colorectal cancer: A systematic review and meta-analysis
S Popat et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q
L Sarli et al.
DISEASES OF THE COLON & RECTUM (2004)
Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen
SB Ho et al.
CLINICAL CANCER RESEARCH (2004)
American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer
AB Benson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Gene expression profiles and molecular markers to predict recurrence of dukes' B colon cancer
YX Wang et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels
MV Mandola et al.
PHARMACOGENETICS (2004)
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer
CM Ribic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer:: A national cancer institute-national surgical adjuvant breast and bowel project collaborative study
CJ Allegra et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry
S Noura et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis
T Lecomte et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients
R Rosenberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Kirsten ras mutations in patients with colorectal cancer:: the 'RASCAL II' study
HJN Andreyev et al.
BRITISH JOURNAL OF CANCER (2001)
Molecular predictors of survival after adjuvant chemotherapy for colon cancer.
T Watanabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Guidelines 2000 for colon and rectal cancer surgery
H Nelson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Molecular staging of early colon cancer on the basis of sentinel node analysis: A multicenter phase II trial
AJ Bilchik et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tumor progression
IHN Wong et al.
CANCER LETTERS (2001)
Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer
C Belluco et al.
ANNALS OF SURGICAL ONCOLOGY (2000)
Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer
R Gryfe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
